3D-QSAR and Molecular Docking Studies of HIV-1 Entry Inhibitors Targeting GP120-CD4 Binding Site

Publisher： Bentham Science Publishers

E-ISSN： 2211-3533|15|2|115-130

ISSN： 2211-3525

Source： Anti-Infective Agents, Vol.15, Iss.2, 2018-01, pp. : 115-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prediction of Binding Affinities for Hydroxamic Acid Derivatives as Urease Inhibitors by Molecular Docking and 3D-QSAR Studies

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 2, 2009-03 ,pp. : 93-100

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Docking and 3D-QSAR Studies on Quinolone-based HDAC Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 7, 2016-08 ,pp. : 577-586

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of Thiazoloquin(az)olin(on)es Derivatives as CD38 Inhibitors Through 3D-QSAR and Molecular Docking Simulations

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 2, 2016-12 ,pp. : 175-185

Bentham Science Publishers

Access to resources Recommend Favorite

3D-QSAR, Molecular Docking and Molecular Dynamics Studies of 2,4- Diarylaminopyrimidine Analogues (DAAP Analogues) as Potent ALK Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 3, 2017-01 ,pp. : 270-286

Bentham Science Publishers

Access to resources Recommend Favorite

The Docking Based 3D-QSAR Studies on Isoindolinone Derived Inhibitors of p53-MDM2 Binding

By  

Letters in Drug Design & Discovery, Vol. 11, Iss. 1, 2014-01 ,pp. : 50-58

Bentham Science Publishers

Access to resources Recommend Favorite